salvianolic acid B (Nanjing Hongqiao Pharmaceutical Technology Institution)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Namesalvianolic acid B (Nanjing Hongqiao Pharmaceutical Technology Institution)
Drug Alias Namesalvianolic acid B
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsCoronary Artery DiseaseAngina Pectoris
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesNanjing Hongqiao Pharmaceutical Technology Research Institute Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesNanjing Hongqiao Pharmaceutical Technology Research Institute Co Ltd
Inactive CompaniesN/A
Active IndicationsCoronary Artery DiseaseAngina Pectoris
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A